Atenolol is a beta-blocker medication used to treat conditions such as hypertension, angina pectoris, and certain cardiac arrhythmias by inhibiting the effects of adrenaline on the heart. Our collection… Read more










![Chemical structure of 4,4'-[[(1-methylethyl)imino]bis[(2-hydroxy-3,1-propanediyl)oxy]]bis-benzeneacetamide-d7
(Atenolol Impurity F)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F44-1-methylethyliminobis2-hydroxy-31-propanediyloxybis-benzeneacetamide-d7-Atenolol-Impurity-F.png&w=3840&q=75)






























![Chemical structure of Atenolol Related Compound E (2-{4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}acetamide) (1044451)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FAtenolol-Related-Compound-E-2-4-3-ethylamino-2-hydroxypropoxyphenylacetamide-1044451.png&w=3840&q=75)








Atenolol is a beta-blocker medication used to treat conditions such as hypertension, angina pectoris, and certain cardiac arrhythmias by inhibiting the effects of adrenaline on the heart. Our collection of Atenolol reference standards supports pharmaceutical laboratories in executing precise analytical testing, quality control, and rigorous method validation. This comprehensive range includes the active pharmaceutical ingredient (API), pharmacopeial and non-pharmacopeial impurities, and structural analogs essential for impurity profiling and forced degradation studies. Researchers also have access to stable isotope labelled compounds and metabolites like Atenolol glucuronide, which are critical for accurate quantification and metabolic pathway investigations. By utilizing these characterized reference materials, laboratories can ensure the consistency, safety, and regulatory compliance of their drug development and batch release processes.